Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Allain

Showing results (171-180 of 187) with videos related to

Pageof 19
Sort By:
Annales De Medecine Interne|January 1, 1990
[Development of memory-improving drugs]H Allain, A Lieury, J M Reymann, et al.
European Journal of Pharmacology|August 26, 1998
Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemiaM J O'Neill, C A Hicks, M A Ward, et al.
Presse Medicale (Paris, France : 1983)|July 27, 2001
[An experience in teaching pharmacology on the internet]H Allain, G Galesne, A Fresnel, et al.
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1983
[Epidural anesthesia using the bupivacaine-fentanyl combination for cesarean section]D Milon, D Bentue-Ferrer, D Noury, et al.
Revue Neurologique|November 27, 2002
[Study of the real situation of improvement by Zopiclone in treatment of insomnia among persons working during night shifts]M A Quera-Salva, P Philip, J Taillard, et al.
Fundamental & Clinical Pharmacology|January 1, 1988
Randomized, double-blind trial of exifone versus cognitive problems in Parkinson's diseaseH Allain, J Denmat, D Bentue-Ferrer, et al.
Journal De Pharmacologie|April 1, 1984
[Proton nuclear magnetic resonance in the pharmacologic study of cerebral edema]L Benoist, H Allain, P Linee, et al.
L'Encephale|November 1, 1994
[Viewpoint on the methodology of drug trials affecting cognition of elderly patients]H Allain, P M Bernard, J F Dartigues, et al.
Journal of Clinical Pharmacology|March 1, 1996
Pharmacodynamics and pharmacokinetics of two dose regimens of befloxatone, a new reversible and selective monoamine oxidase inhibitor, at steady state in healthy volunteersA Patat, F le Coz, C Dubruc, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1991
Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians: a randomized double-blind crossover studyH Allain, F Le Coz, F Goulley, et al.
Pageof 19

Showing results (171-180 of 187) with videos related to

Sort By:
Pageof 19
Annales De Medecine Interne|January 1, 1990
[Development of memory-improving drugs]H Allain, A Lieury, J M Reymann, et al.
European Journal of Pharmacology|August 26, 1998
Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemiaM J O'Neill, C A Hicks, M A Ward, et al.
Presse Medicale (Paris, France : 1983)|July 27, 2001
[An experience in teaching pharmacology on the internet]H Allain, G Galesne, A Fresnel, et al.
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1983
[Epidural anesthesia using the bupivacaine-fentanyl combination for cesarean section]D Milon, D Bentue-Ferrer, D Noury, et al.
Revue Neurologique|November 27, 2002
[Study of the real situation of improvement by Zopiclone in treatment of insomnia among persons working during night shifts]M A Quera-Salva, P Philip, J Taillard, et al.
Fundamental & Clinical Pharmacology|January 1, 1988
Randomized, double-blind trial of exifone versus cognitive problems in Parkinson's diseaseH Allain, J Denmat, D Bentue-Ferrer, et al.
Journal De Pharmacologie|April 1, 1984
[Proton nuclear magnetic resonance in the pharmacologic study of cerebral edema]L Benoist, H Allain, P Linee, et al.
L'Encephale|November 1, 1994
[Viewpoint on the methodology of drug trials affecting cognition of elderly patients]H Allain, P M Bernard, J F Dartigues, et al.
Journal of Clinical Pharmacology|March 1, 1996
Pharmacodynamics and pharmacokinetics of two dose regimens of befloxatone, a new reversible and selective monoamine oxidase inhibitor, at steady state in healthy volunteersA Patat, F le Coz, C Dubruc, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1991
Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians: a randomized double-blind crossover studyH Allain, F Le Coz, F Goulley, et al.
Pageof 19